Saturday, 7 May 2016

The importance of botanical treatments in traditional societies and challenges in developing countries

Volume 52, November 01, 2015, Pages 297-307

The importance of botanical treatments in traditional societies and challenges in developing countries  (Review)

a  Department of Paediatrics and Child Health, Makerere University College of Health Sciences and Mulago Hospital, Kampala, Uganda
b  Astrid Lindgren Children's Hospital, Department of Women's and Children's Health, Neuropediatric Research Unit, Karolinska Institutet, Stockholm, Sweden 

Abstract

Epilepsy is one of the most common neurological conditions worldwide, with many affected persons found in Asia, Latin America, and sub-Saharan Africa. Relatedly, the large majority found in these regions does not receive the appropriate therapy with antiepileptic drugs (AEDs), stemming from various reasons among which are lack of access to AEDs, social stigma, and negative cultural attitudes. The presence of epilepsy resistant to the available AEDs coupled with the frequent AED side effects has further fueled the widespread and growing use of botanicals as alternative therapy in several traditional societies in these developing countries since people with epilepsy (PWE) consider them as safe and effective. There have, however, been few botanicals that have been examined for their pharmacological activities related to traditional uses, and there is hardly any conclusive evidence regarding their efficacy in humans or knowledge about the exact mechanism(s) of action. This review discusses some botanical treatments that have been used for epilepsy in developing countries and the challenges faced. This article is part of a Special Issue entitled "Botanicals for Epilepsy". © 2015 Elsevier Inc.

Author keywords

Botanicals; Challenges; Efficacy; Epilepsy; Safety; Traditional societies

Indexed keywords

EMTREE drug terms: benzodiazepine receptor; br 16a; cannabidiol; carbamazepine; herbaceous agent; phenobarbital; phenytoin
EMTREE medical terms: Africa south of the Sahara; anticonvulsant activity; Asia; Ayurveda; developing country; drug efficacy; drug safety; electric shock; epilepsy; geographic distribution; human; Korean medicine; medicinalplant; nonhuman; phytochemistry; plant leaf; plant root; Review; sedation; South and Central America; unspecified side effect
Chemicals and CAS Registry Numbers: cannabidiol, 13956-29-1; carbamazepine, 298-46-4, 8047-84-5; phenobarbital, 50-06-6, 57-30-7, 8028-68-0; phenytoin, 57-41-0, 630-93-3
Drug tradename: mentat.
ISSN: 15255050 CODEN: EBPEASource Type: Journal Original language: English
DOI: 10.1016/j.yebeh.2015.06.017Document Type: Review
Publisher: Academic Press Inc.
  Kakooza-Mwesige, A.; P.O. Box 7072, Uganda; email:angelina_kakooza@yahoo.co.uk
© Copyright 2015 Elsevier B.V., All rights reserved.